RUN Rheumatology
(Die Seite wurde neu angelegt: „ {{tp|p=32355607|t=ä. What Does the COVID-19 Pandemic Mean for Rheumatology Patients?|pdf=|usr=}} {{tp|p=32321633|t=2020. Implications of COVID-19 for the man…“) |
|||
| Zeile 19: | Zeile 19: | ||
{{tp|p=32376399|t=2020. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion |pdf=|usr=}} | {{tp|p=32376399|t=2020. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion |pdf=|usr=}} | ||
{{tp|p=32380317|t=2020. (COVID-19) epidemic: What are the risks for systemic sclerosis patients?|pdf=|usr=}} | {{tp|p=32380317|t=2020. (COVID-19) epidemic: What are the risks for systemic sclerosis patients?|pdf=|usr=}} | ||
| − | + | {{tp|p=32352362|t=2020. Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: A perspective from China |pdf=|usr=}} | |
{{tp|p=32348046|t=2020. Rhumatologie et COVID-19 |pdf=|usr=}} | {{tp|p=32348046|t=2020. Rhumatologie et COVID-19 |pdf=|usr=}} | ||
{{tp|p=32348045|t=2020. Maladies autoimmunes dans le contexte de la pandemie COVID-19 |pdf=|usr=}} | {{tp|p=32348045|t=2020. Maladies autoimmunes dans le contexte de la pandemie COVID-19 |pdf=|usr=}} | ||
Version vom 15. Juni 2020, 20:21 Uhr
32355607 ä. What Does the COVID-19 Pandemic Mean for Rheumatology Patients?
32321633 2020. Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
32209661 2020. The Rheumatologist s Role in COVID-19
32335514 2020. The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic
32368736 2020. Global rheumatology in the time of COVID-19
32376774 2020. Impact of COVID-19 pandemic on SLE: beyond the risk of infection
32346775 ä. Osteoporosis in the age of COVID-19
32297225 ä. Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy
32382245 ä. Comment et pourquoi les rhumatologues sont importants face � la crise du COVID-19�??
32342184 ä. Aktuelle Handlungsempfehlungen der Deutschen Gesellschaft f�r Rheumatologie f�r die Betreuung von Patienten mit rheumatischen Erkrankungen w�hrend der SARS-CoV?2/Covid�19-Pandemie
32303821 ä. Einstellung von Patienten mit entz�ndlich-rheumatischen Erkrankungen zur immunsuppressiven Therapie im Rahmen der COVID-19 Pandemie ? eine Situationsanalyse
32340996 2020. Managing patients with rheumatic conditions during the covid-19 pandemic
32345617 2020. Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey
32345619 2020. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic
32219857 ä. Advice regarding COVID?19 and use of immunomodulators, in patients with severe dermatological diseases
32376399 ä. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
32355444 2020. Implications du COVID-19�pour la prise en charge des rhumatismes inflammatoires chroniques?
32376399 2020. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
32380317 2020. (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
32352362 2020. Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: A perspective from China
32348046 2020. Rhumatologie et COVID-19
32348045 2020. Maladies autoimmunes dans le contexte de la pandemie COVID-19
